| Literature DB >> 28964968 |
Jerid W Robinson1, Jeremy R Egbert2, Julia Davydova3, Hannes Schmidt4, Laurinda A Jaffe5, Lincoln R Potter6.
Abstract
Activating mutations in fibroblast growth factor receptor 3 (FGFR3) and inactivating mutations of guanylyl cyclase-B (GC-B, also called NPRB or NPR2) cause dwarfism. FGF exposure inhibits GC-B activity in a chondrocyte cell line, but the mechanism of the inactivation is not known. Here, we report that FGF exposure causes dephosphorylation of GC-B in rat chondrosarcoma cells, which correlates with a rapid, potent and reversible inhibition of C-type natriuretic peptide-dependent activation of GC-B. Cells expressing a phosphomimetic mutant of GC-B that cannot be inactivated by dephosphorylation because it contains glutamate substitutions for all known phosphorylation sites showed no decrease in GC-B activity in response to FGF. We conclude that FGF rapidly inactivates GC-B by a reversible dephosphorylation mechanism, which may contribute to the signaling network by which activated FGFR3 causes dwarfism.Entities:
Keywords: Achondroplasia; C-type natriuretic peptide; Cyclic GMP; Dwarfism; Fibroblast growth factor; Guanylyl cyclase; NPR2
Mesh:
Substances:
Year: 2017 PMID: 28964968 PMCID: PMC5651182 DOI: 10.1016/j.cellsig.2017.09.021
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315